Stock Rating Report for AIS
|
|
Stock Information
| Ticker |
AIS |
| Company Name |
Antares Pharma Inc |
| Current Price |
$2.68 |
| Previous Close |
$2.68 |
| Industry |
Medical Instruments and Supplies |
| Sector |
HEALTHCARE |
| Long Stop Loss |
Members Only |
| Short Stop Loss |
Members Only |
| Expected Move |
Members Only |
| Optionable? |
Yes
|
StockProphet Ratings
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Sector Risks
Chart
We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for AIS. However, we only show it to our subscribers.
We update our ratings and stop losses EVERY WEEK.
Don't miss out on what we recommend for Antares Pharma Inc next week. Sign up today and start making money!
Demand Fundamentals
|
Demand Technicals
Company Profile
Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone- Medi-Jector Vision for insulin- Vibex disposable pressure assisted auto injectors that enables a controlled pressure delivery of drugs into the body utilizing a spring power source- and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The company also provides Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder- Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause- LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction- and Nestorone contraceptive formulation products, which has completed Phase II clinical trials. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements with Teva Pharmaceutical Industries, Ltd.- Ferring Pharmaceuticals BV- JCR Pharmaceuticals Co., Ltd.- BioSante Pharmaceuticals, Inc.- Jazz Pharmaceuticals- and Population Council. The company was founded in 1979 and is based in Ewing, New Jersey.
|
Latest News
| Fri, 03 Feb 2012 22:33:50 GMT | 3 Hot Picks On The Way Up | | Thu, 02 Feb 2012 15:25:46 GMT | Antares's Promising New RA Treatment Method Revisited | | Wed, 01 Feb 2012 15:33:51 GMT | On The Fly: Analyst Upgrade Summary | | Tue, 31 Jan 2012 20:58:12 GMT | Investors Need To Know Why Antares Will Have Exponential Growth In 2012 | | Tue, 31 Jan 2012 20:51:15 GMT | Small Biotech Companies With Big, Promising Pipelines | | Tue, 31 Jan 2012 08:27:54 GMT | Top Q4 Undervalued Buys And Sells Of Vanguard's $632 Billion In 13-F Assets | | Mon, 30 Jan 2012 22:52:17 GMT | Antares's New RA Treatment Method Has Large Market Potential | | Fri, 27 Jan 2012 20:06:53 GMT | Anturol Equals A Triple-Digit PPS Jump In Antares's Share Price, Here's Why | | Thu, 26 Jan 2012 11:13:46 GMT | Teva Partnership And Pipeline Potential: Why Antares Is A Buy | | Wed, 25 Jan 2012 20:41:09 GMT | Wall Street's Best Hidden Stocks | | Wed, 25 Jan 2012 13:20:00 GMT | Antares Pharma and Boston Scientific Benefit From Renewed Industry Optimism | | Wed, 25 Jan 2012 02:51:57 GMT | Stock Boards: Weeding Through The Nonsense, Getting To The Facts. | | Tue, 24 Jan 2012 21:43:21 GMT | 4 Low-Priced Biotech Stocks Poised To Rally In 2012 | | Mon, 23 Jan 2012 21:03:44 GMT | Investing In Small Cap Bio-Pharma: Striking It Rich Or Going Bust | | Mon, 23 Jan 2012 18:02:53 GMT | The Best Biotech Stocks Of 2012 | | Mon, 23 Jan 2012 17:31:20 GMT | Top Three 'Penny-Land' Biotech Stock Picks | | Sat, 21 Jan 2012 02:41:24 GMT | Buy, Sell, or Hold: Antares Pharma | | Wed, 18 Jan 2012 19:34:57 GMT | A Bio-Pharma Buy And Sell List: Part 2 | | Wed, 18 Jan 2012 19:33:35 GMT | A Bio-Pharma Buy And Sell List: Part 1 | | Tue, 17 Jan 2012 18:58:42 GMT | Acorda Therapeutics: A Mid Cap Bio-Pharma Poised For Big Long Term Returns | News provided by Yahoo! Finance |
|
|
|
|